Banka BioLoo Limited
Banka BioLoo Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 20,020 | 235.8 | 2.02 | 0.96 | 73.09 |
| Oct 2026 | 22,740 | 221.0 | 1.89 | 0.96 | 68.51 |
| Oct 2026 | 21,934 | 243.2 | 1.88 | 0.96 | 68.10 |
Banka BioLoo Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 105,513,000.0 | 176,746,000.0 | 152,649,000.0 | 130,118,000.0 |
| Net Profit | -134,000.0 | 16,041,000.0 | -1,488,000.0 | -10,847,000.0 |
| EPS | -0.0 | 1.4 | -0.1 | -1.0 |
Banka BioLoo Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 570,924,000.0 | 541,736,000.0 | 499,962,000.0 | 423,498,000.0 | — |
| Net Profit | 3,513,000.0 | -89,151,000.0 | -6,525,000.0 | 25,389,000.0 | — |
| EPS | 0.3 | -8.2 | -0.6 | 2.3 | — |
Banka BioLoo Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,007,101,000.0 | 821,551,000.0 | 774,227,000.0 | 652,074,000.0 | — |
| Total Liabilities | 581,351,000.0 | 505,698,000.0 | 376,609,000.0 | 251,085,000.0 | — |
| Total Equity | 395,556,000.0 | 315,138,000.0 | 397,203,000.0 | 400,989,000.0 | — |
Owes vs Owns
Banka BioLoo Limited owed ₹0.58 for every ₹1 it owned in Mar 2026, up from ₹0.39 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.58× | 0.62× | 0.49× | 0.39× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Banka BioLoo Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
How it's funded — Mar 2026
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 13.2 | 6.7 | 4.4 | 1.3 |
| Receivables | 19.0 | 14.4 | 10.9 | 22.9 |
| Inventory | 6.1 | 5.8 | 8.3 | 8.7 |
| Fixed assets (tangible) | 28.1 | 23.4 | 21.5 | 13.7 |
| Intangible assets | 0.1 | 0.1 | 0.4 | 0.4 |
| Long-term investments | 0.1 | 0.0 | 0.0 | 0.1 |
| Other assets | 34.1 | 31.7 | 31.9 | 18.0 |
| Liabilities & equity | ||||
| Short-term debt | 26.3 | 22.6 | 13.9 | 10.1 |
| Long-term debt | 13.0 | 11.7 | 10.9 | 4.9 |
| Payables | 8.0 | 5.4 | 3.9 | 3.1 |
| Other liabilities | 10.8 | 10.9 | 8.9 | 6.9 |
| Shareholders' equity | 42.6 | 31.6 | 39.8 | 40.1 |
| Net tangible assets | 39.5 | 31.4 | 39.3 | 39.7 |
Banka BioLoo Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 10,526,000.0 | 8,685,000.0 | 27,630,000.0 | 73,531,000.0 | — |
| Investing Activities | -21,598,000.0 | -60,159,000.0 | -100,692,000.0 | -57,181,000.0 | — |
| Financing Activities | 110,737,000.0 | 50,820,000.0 | 67,762,000.0 | -33,292,000.0 | — |